| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $9.9M | — | +27.3% |
| SG&A Expense | $5.0M | — | +35.9% |
| Operating Income | -$14.9M | — | -30.0% |
| Pre-tax Income | -$13.2M | — | -27.6% |
| Income Tax | -$20K | — | -81.8% |
| Net Income | -$13.2M | — | -27.6% |
| EPS (Basic) | -$0.09 | — | +0.0% |
| EPS (Diluted) | -$0.09 | — | +0.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $19.4M | +2.6% | +0.2% |
| Short-term Investments | $152.4M | -10.0% | +81.6% |
| Current Assets | $176.1M | -8.1% | +66.7% |
| Total Assets | $179.6M | -7.2% | +67.8% |
| Current Liabilities | $7.1M | -27.0% | +3.6% |
| Total Liabilities | $7.5M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$16.7M | — | -23.8% |
| Capital Expenditures | $102K | — | — |
| Investing Cash Flow | $17.0M | — | +270.5% |
| Financing Cash Flow | $222K | — | -97.4% |
| Free Cash Flow | -$16.8M | — | — |
| -0.9% |
| Stockholders' Equity | $172.1M | -6.1% | +73.1% |